Business Description
Galecto Inc
NAICS : 541714
SIC : 2834
ISIN : US36322Q1076
Share Class Description:
GLTO: Ordinary SharesDescription
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 614.94 | |||||
| Equity-to-Asset | 0.9 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 43.2 | |||||
| 3-Year EPS without NRI Growth Rate | 43.8 | |||||
| 3-Year FCF Growth Rate | 45 | |||||
| 3-Year Book Growth Rate | -43.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.32 | |||||
| 9-Day RSI | 33.91 | |||||
| 14-Day RSI | 32.17 | |||||
| 6-1 Month Momentum % | -57.17 | |||||
| 12-1 Month Momentum % | -64.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.68 | |||||
| Quick Ratio | 8.68 | |||||
| Cash Ratio | 8.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.4 | |||||
| Shareholder Yield % | 8.07 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -74.35 | |||||
| ROA % | -61.76 | |||||
| ROIC % | -450.38 | |||||
| ROC (Joel Greenblatt) % | -7377.66 | |||||
| ROCE % | -70.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.29 | |||||
| Price-to-Tangible-Book | 0.29 | |||||
| EV-to-EBIT | 0.67 | |||||
| EV-to-Forward-EBIT | -0.19 | |||||
| EV-to-EBITDA | 0.68 | |||||
| EV-to-Forward-EBITDA | -0.17 | |||||
| EV-to-FCF | 0.53 | |||||
| Price-to-Net-Current-Asset-Value | 0.33 | |||||
| Price-to-Net-Cash | 0.36 | |||||
| Earnings Yield (Greenblatt) % | 149.25 | |||||
| FCF Yield % | -393.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GLTO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Galecto Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -19.2 | ||
| Beta | 1.48 | ||
| Volatility % | 66.33 | ||
| 14-Day RSI | 32.17 | ||
| 14-Day ATR ($) | 0.383473 | ||
| 20-Day SMA ($) | 5.297785 | ||
| 12-1 Month Momentum % | -64.62 | ||
| 52-Week Range ($) | 4.4006 - 23.5 | ||
| Shares Outstanding (Mil) | 1.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Galecto Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Galecto Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Galecto Inc Frequently Asked Questions
What is Galecto Inc(GLTO)'s stock price today?
The current price of GLTO is $4.96. The 52 week high of GLTO is $23.50 and 52 week low is $4.40.
When is next earnings date of Galecto Inc(GLTO)?
The next earnings date of Galecto Inc(GLTO) is 2025-02-01 Est..
Does Galecto Inc(GLTO) pay dividends? If so, how much?
Galecto Inc(GLTO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers